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Background: Pharmacists are considered medication experts but are underutilized and exist 
mainly at the periphery of the Malaysian primary health care team. Private general practitio-
ners (GPs) in Malaysia are granted rights under the Poison Act 1952 to prescribe and dispense 
medications at their primary care clinics. As most consumers obtain their medications from 
their GPs, community pharmacists’ involvement in ensuring safe use of medicines is limited. 
The integration of a pharmacist into private GP clinics has the potential to contribute to quality 
use of medicines. This study aims to explore health care consumers’ views on the integration 
of pharmacists within private GP clinics in Malaysia.
Methods: A purposive sample of health care consumers in Selangor and Kuala Lumpur, 
Malaysia, were invited to participate in focus groups and semi-structured interviews. Sessions 
were audio recorded and transcribed verbatim and thematically analyzed using NVivo 10. 
Results: A total of 24 health care consumers participated in two focus groups and six semi-
structured interviews. Four major themes were identified: 1) pharmacists’ role viewed mainly as 
supplying medications, 2) readiness to accept pharmacists in private GP clinics, 3) willingness 
to pay for pharmacy services, and 4) concerns about GPs’ resistance to pharmacist integration. 
Consumers felt that a pharmacist integrated into a private GP clinic could offer potential benefits 
such as to provide trustworthy information on the use and potential side effects of medications 
and screening for medication misadventure. The potential increase in costs passed on to con-
sumers and GPs’ reluctance were perceived as barriers to integration. 
Conclusion: This study provides insights into consumers’ perspectives on the roles of phar-
macists within private GP clinics in Malaysia. Consumers generally supported pharmacist 
integration into private primary health care clinics. However, for pharmacists to expand their 
capacity in providing integrated and collaborative primary care services to consumers, barriers 
to pharmacist integration need to be addressed.
Keywords: pharmacist integration, private clinic, general practitioners, health care consumer, 
Malaysia
Background
Malaysia’s health care system is a two-tier system consisting of the public and private 
sector. The public health care system, funded fully by the government and financed 
mainly from public tax revenue, provides services through a network of tertiary care 
centers, general hospitals, district hospitals, and public health clinics.1 The private sec-
tor, which consists of private hospitals and general practitioner (GP) clinics, provides 
both curative and preventive health care services on a non-subsidized, fee-for-service 
basis and mainly caters for those who can afford to pay.1
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Pharmacists in the Malaysian primary care setting are 
mainly located in government-owned public health clinics 
(known as “klinik kesihatan”) and community pharmacies. 
Pharmacy practice in public health clinics and community 
pharmacies are very different. Pharmacists in the public health 
clinics possess complete control over the supply of medicines.2 
Pharmacists in these public health clinics also enroll patients 
with chronic diseases such as diabetes in a Medication Therapy 
Adherence Clinic (MTAC) program.3 For example, the Dia-
betes Medication Therapy Adherence Clinic is a pharmacist 
managed clinic aimed at improving medication adherence 
and glycemic control in diabetic patients in order to prevent 
diabetes-related complications. The pharmacist undertakes 
a medication review for the patient, identifies pharmaceuti-
cal care issues, provides recommendations and solutions to 
drug related problems, educates the patient, and monitors the 
therapeutic outcome until the therapeutic goal is achieved. 
The patient is followed up at a monthly or two monthly inter-
vals by the pharmacist. Other MTAC services are available 
depending on patient needs such as warfarin MTAC, asthma 
MTAC, and renal transplant MTAC. Community pharmacists, 
unlike their counterparts, operate under rigid conditions and 
are often underutilized.2 Fewer than two prescriptions a day 
are filled at community pharmacies in Malaysia4 as private 
GPs are granted rights under the Poison Act 1952 to prescribe 
and dispense medications at their clinics. The main reason for 
the general public to visit a community pharmacy in Malaysia 
is usually to purchase a particular prescription medication or 
over-the-counter products.4
With the present health care system in Malaysia, primary 
care exerts only a limited gatekeeper function since many 
consumers can bypass a referral from a GP and directly 
attend specialists in hospitals with an additional fee.1,5 
Consumers may receive treatments at different clinics or 
hospitals. As consumer details are not often communicated 
between the attending health care professionals, medication-
related problems may occur. More complicated medication 
regimens, the inability to properly recall the regimen, the 
greater number of physicians consulted regularly, and the 
greater number of preparations used are associated with an 
increased risk of hospitalization related to non-compliance.6 
Failure to integrate comprehensive care to patients can lead 
to an excessive burden onto hospital services, with acute 
wards becoming overwhelmed.7 With better coordinated 
care and prevention of adverse events and complications, 
savings on treatment costs and resources can be realized.5
Findings from the “National survey on the use of medi-
cines by Malaysian Consumers 2012” showed that 56% of 
consumers consult a government doctor when experiencing 
any health problems while 28% consult a private doctor.8 The 
study also demonstrated that 43.5% of consumers still did not 
understand the proper use of their medicines, unaware of their 
trade name (50.2%), and were not aware of common side effects 
(35.8%).8 Health care consumer education and counseling is 
perhaps one of the neglected areas in the private medical prac-
tice in Malaysia. The reason for this is the unavailability of the 
pharmacist at the dispensing window.9 In Malaysia, physicians 
are allowed to operate a small dispensary within their clinic. 
Unfortunately, the person who dispenses the medicine is not 
a pharmacist and this can be another factor that results in poor 
communication.9 Consumers’ understanding and level of sat-
isfaction may be better if a pharmacist briefs them about the 
disease and counsel on the safe use of medicine.
Health care reform to improve efficiency, effectiveness, 
consumers’ choice, and equity has become an increasingly 
important agenda for policy change in Malaysia.10 The concept 
of “1 Care,” the proposed re-structuring of the health system, 
is discussed with emphasis on the reform in the primary health 
care delivery system.11 The reforms are aimed at addressing 
three main concerns on seamless integration of care especially 
for the management of chronic diseases, ensuring universal 
coverage, and responsiveness of the health system in the face 
of increasing consumer expectations and safety.11 Pharmacists 
are medication experts and are easily accessible hence they 
can potentially contribute to the reform objectives. 
Previous studies have shown that GPs do not conduct 
medication reviews in all patients who present for repeat 
prescription.12–14 Collaborative medicines management ser-
vices delivered by pharmacists and GPs have already been 
successful in identifying and resolving medication-related 
problems, improving patient outcomes, and optimizing 
drug use and costs.15–20 Such services include pharmacist-led 
medication reviews, where pharmacists assess medications, 
monitor disease progression, and provide recommendations 
to GPs on a medication management plan. 
Internationally, health care reforms have led to initiatives 
in integrating non-dispensing pharmacists into primary health 
care teams. Some of the broader examples of successful col-
laboration are detailed below:
•	 Medicines review in New Zealand,21 Taiwan,22 the 
Netherlands,23 and Australia24 is a collaborative service 
between pharmacists, GPs, and occasionally with nurses. 
Remuneration for these services vary from none (eg, in 
New Zealand, due to pharmacies competing for dispensing 
fees as part of the medicines review, some are providing 
reviews for free)25 to pharmacists receiving a consultation 
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fee on completion (eg, Taiwan, the Netherlands). In Aus-
tralia, remuneration is provided to both pharmacists and 
GPs who participate in specific medicines review pro-
grams such as Home Medicines Review and Residential 
Medication Management Review.24
•	 Enhanced and local services are provided by community 
pharmacists in the UK in addition to the traditional dis-
pensing services. Examples of enhanced and local services 
include stop smoking schemes, supervised administra-
tion (of methadone for drug misusers), consumer group 
directions (for example to supply emergency hormones 
and nicotine replacement therapy), and minor ailment 
schemes.24 Other health care professionals use the phar-
macy’s premises and facilities to provide all of the Primary 
Care Trust’s enhanced and local services. All enhanced 
and local services are paid for by the local Primary Care 
Trust.24 A study by Bradley et al looking at the outcomes 
of the enhanced and local service pilots found that co-
locating pharmacies and GP practices facilitated the 
integration of pharmacists into primary health care teams 
through the benefits of regular face-to-face contact.26
•	 Integrating family Medicine and Pharmacy to Advance 
primary Care Therapeutics (IMPACT) in Canada was an 
initiative by the Primary Healthcare Transition Fund to 
place pharmacists within primary health care teams and is 
receiving widespread acceptance both in Canada and inter-
nationally.27 The IMPACT project was a multisite dem-
onstration involving seven pharmacists, 70 physicians, 
and up to 150,000 consumers in a 2-year program.28 In 
the study, at least one drug-related problem was identified 
and assessed by the pharmacist in 93.8% consumers.28 The 
total number of adverse drug reactions or potential adverse 
drug reactions identified was 315 (7.9% of all drug-related 
problems identified).28 Physicians noted many benefits to 
working with pharmacists such as having a colleague who 
provided reliable drug information, getting fresh perspec-
tives, and increased clinical security.28 From 2006–2007, 
the province of Ontario provided significant support for 
the introduction of approximately 87 pharmacists working 
in approximately 62 family health teams.29 
•	 Primary health care clinics/medical centers with a pharma-
cist were identified in countries such as New Zealand. For 
example, the “Integrated Family Health Centres” is a new 
program under the Government initiative “Better, Sooner, 
More Convenient Primary Healthcare” and looks to move 
GPs, nurses, pharmacists, and allied health professionals 
within (or linked in with) the same health center in order 
to enhance multidisciplinary care and cost reduction.30
Previous work has been done in Australia to describe the 
opinions of health care consumers toward pharmacist integra-
tion into the general practice environment. In the study by Free-
man et al, the health care consumer group viewed medication 
review, medication counseling, health care consumer advo-
cacy, providing medication profile print-outs, and prescribing 
(prescription renewal) as a positive role.31 Remuneration was 
viewed as a facilitator and barrier to the health care consumer 
group. The health care consumer group also identified that 
promotion of services provided by the pharmacist could help 
the facilitation into the general practice setting. Barriers to 
facilitation include physical space and GPs’ reluctance.31 
In a separate Australian study by Tan et al, interviews 
were conducted with consumers on their experiences with 
pharmacists within the Australian general practice clinics. 
The study found that participants appreciated the time spent 
with the practice pharmacist specifically discussing their 
medications, in comparison with their GP or community 
pharmacist who were often viewed as being too busy.32 
Although consumers were generally receptive to seeing the 
practice pharmacist, some still preferred consulting their GP 
about their medicines.32 
Integrating pharmacists into private GP clinics is a new 
approach to Malaysia. To date, no studies have explored the 
views of Malaysian health care consumers on pharmacist 
integration into private GP clinics. This study aimed to 
explore Malaysian consumers’ views on the integration of 
pharmacists within private GP clinics in Malaysia.
Ethics approval
This study was approved by the International Medical Uni-
versity Joint-Committee (IMU-JC) of Research and Ethics 
Committee (IMU R 117/2013). 
Methods 
Qualitative methods were used since little is known about 
consumers’ opinions on extended roles of pharmacists in a 
GP clinic setting. Exploratory techniques using focus groups 
and semi-structured interviews with health care consumers 
were employed. Semi-structured interviews were offered in 
addition to focus groups to provide participants a choice to 
participate at an agreeable time and place when focus group 
arrangements were not favorable. 
Sample and recruitment
A combination of purposive, snowball, and convenience 
sampling was used to obtain a sample of health care consum-
ers. In this study, health care consumers refer to individuals 
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who use health care products (including prescription and 
non-prescription medicine, over-the-counter products, vita-
mins, and supplements) and services, either for themselves or 
another family member that they care for. Letters of invita-
tion were disseminated through peak consumer associations 
for participant recruitment to participate in the focus group 
or semi-structured interview. Participants had to be English-
speaking, aged 18 years or older, and able to give informed 
consent. This study was carried out with participants from 
different backgrounds and experiences to increase data cred-
ibility and prevent information bias. Interviews and analyses 
were performed in an iterative manner until no new themes 
emerged. 
Interview guide and validity
An interview schedule (Table 1) was developed based on the 
discussions with representatives of peak professional organi-
zations and a review of the literature.31,32 Seeding questions 
were provided under each topic to encourage participant 
engagement and examples of potential scenarios provided 
where necessary. The schedule was used to direct the focus 
groups and interviews. The face validity of the interview 
schedule was tested with one health care consumer. Immedi-
ately following the interview, the researcher (PSS) discussed 
any queries, concerns, or issues related to the questions with 
the participants. Queries were addressed and minor amend-
ments made to the interview guide. 
Data collection
Data were collected between September 2013 and December 
2013. All interviews and focus groups were conducted in a 
private discussion room or meeting room of the researcher’s 
(PSS) university. Immediately prior to each focus group/
semi-structured interview, participants were asked to com-
plete a short (anonymous) demographic questionnaire to 
provide basic background of the participants. Written and 
verbal consent was obtained from all participants prior to the 
focus groups and interviews. All interviews were conducted 
according to participant preference at a mutually convenient 
place and time and facilitated by PSS. Throughout the focus 
groups and interviews, field notes were taken by PSS to 
capture key points, follow-up questions, and non-verbal 
activities from participants. The semi-structured interviews, 
focus group discussions, and field notes served to triangulate 
the data. Recruitment and interviews continued until data 
saturation was collectively reached, ie, where new informa-
tion discovered does not add necessary points to the overall 
theory or framework.33 Focus groups and interviews were 
audio-recorded and transcribed verbatim (PSS and VM).
Data analysis
Data management was facilitated using NVivo 10 software 
(QSR International, Melbourne, VIC, Australia) to ensure sys-
tematic analysis of data. Units of information were identified 
and coded to represent an idea, opinion, or attitude. Themes 
were generated from the data set by making connections 
within and between participants using the general inductive 
approach. During the interpretation stage, investigators devel-
oped themes from reviews of all transcripts which offered 
possible explanations for what was happening within the 
data. This process was influenced both by the original study 
objectives and by new concepts generated inductively (con-
sumers’ experiences and views) from the data. The emergent 
themes were coded independently between two researchers 
Table 1 Key topics covered in interview guide
Potential roles of integrated pharmacist in private GP clinic
a) What are your views on the services and care that you receive from private gP clinics? 
b) What do you feel is the main role of pharmacists within our health care system?
c) What are your views and opinions on integrating a pharmacist into private gP clinics?
d) What roles would you see a pharmacist performing in a private gP clinic?
e) What roles would you not want to see a pharmacist performing in a private gP clinic?
f) Would you like to see a pharmacist in private gP clinics performing roles mentioned earlier?
Barriers to pharmacist integration into private GP clinic
a) What do you think are the barriers or challenges to have a pharmacist integrated into a private gP clinic?
Facilitators to pharmacist integration into private GP clinic
a) What do you think would facilitate or encourage pharmacist integration into private gP clinics
Benefits of pharmacist integration into private GP clinic
a)	What	do	you	think	are	the	benefits	of	having	a	pharmacist	to	work	together	with	the	GPs	within	the	private	GP	clinics
Remuneration to pharmacist
a) how do you think services provided by a pharmacist in private gP clinics should be funded?
Abbreviation: gP, general practitioner.
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(PSS and VM). Regular team meetings by the researchers 
facilitated critical exploration of participant responses, 
discussion of deviant cases, and agreement on recurring 
themes. Any discrepancies were resolved by discussion 
with the attempt to reach a consensus. All the quotes were 
screened and those that best captured the essence of the 
themes were extracted.
Results
A total of 24 health care consumers participated in two 
focus groups and six semi-structured interviews. Partici-
pants resided in areas within Selangor and Kuala Lumpur. 
Mean age (± standard deviation) of the participants was 
37.3 (±11.9) years, with a range of 24 years to 64 years. 
Demographic characteristics of participants are listed in 
Table 2.
Four major themes emerged from the focus groups and 
semi-structured interviews and were supported by illustrative 
quotes from the participants (C = consumer).
Pharmacists’ role viewed mainly as 
supply of medications
supply of medicines
Participants mainly viewed community pharmacists’ role as 
suppliers of medicines and sale of over-the-counter medica-
tion, non-medicinal and beauty products. 
Currently I think most of them are just over the counter 
selling medicine…and then those controlled medicine that 
need to go through a pharmacist, then we have to ask from 
them permission to sell it to us, that’s what I feel. [C2]
In fact many of the community pharmacies except for 
the big ones, there are no pharmacists around […] Because 
they sell a lot of other products […] non medicinal type […] 
like shampoo. [C12]
supply of medicines with consumer education 
Participants felt that pharmacists should provide information 
and education to consumers on the medicines supplied. Most 
participants envisage a good pharmacist to be able to assess 
and decide the best choice of treatment for consumers instead 
of merely supplying the medicine. 
That’s why the pharmacist role to advise the consumers on 
the effect, if it’s really agreeable to you or not, the explana-
tion must be there, the education. [C22]
I think a good pharmacist should not only take out the 
medicine and give to consumer. They should actually [...] 
when somebody like me, I go like can I get this specific 
antibiotic, they should actually say are you sure you want 
this or you know have you been taking this before, like do 
a check on the patient itself [...] So they should be more 
passionate about their job. [C14]
supply of health supplements with health promotion
Some participants saw pharmacists as being helpful in pro-
moting general health and wellness particularly in the aspects 
of diet and education on vitamins and food supplements. 
Especially for supplements, we don’t go and see doctors. If 
there’s a pharmacist there then will be much better. Then 
we will get advice you see from the pharmacist. [C12]
We will approach the pharmacist as compared to the 
doctor. So that would be the opportunity and because we 
are going for healthy lifestyle so the pharmacist will play 
a more important role in that sense. [C11]
To guide not only your medication, you have to see that 
your food intake is also very important. So of course they 
[pharmacists] have to know little bit about diet on diabetic 
because a lot of them don’t control their sugar you know, 
they just eat what they like. [C3]
consumers’ readiness to accept 
pharmacists in private gP clinics
Difficulty	in	envisioning	other	roles	of	pharmacists	
besides the supply of medications
Participants have difficulty envisioning other roles 
pharmacists can perform. Participants were not aware of what 
pharmacists are capable of doing in the private GP clinics 
besides dispensing medicines. They indicated that this was 
due to their exposure to pharmacy services only at hospitals 
and community pharmacies. 
Table 2 Demographic characteristics of participants 
Characteristics Total participants (n)
interview method 24
Focus group 1
Focus group 2
semi-structured interviews
7
11
6
sex
Male
Female
7
17
ethnicity
Malay
chinese 
indian
7
12
5
highest level of education 
secondary
college/university
Post-graduate
1
20
3
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I haven’t really thought about that. But because our 
exposure to pharmacists is only at the hospitals and at the 
community pharmacy. So I don’t know how you know the 
pharmacists can help. [C12]
I don’t know because in my mind, the role of the phar-
macist is to dispense the medicine. [C24]
Most participants did not know what areas pharmacists 
are trained in but generally felt that they could play an impor-
tant role within the health care system. Participants agree that 
pharmacists should undergo continuous pharmacy skills and 
knowledge development to keep themselves updated with 
the latest medicine information.
And I believe that pharmacist can play a greater role you 
know in Malaysia rather than just giving medication. [C6]
They [pharmacists] are a waste of their talent. Most of 
them are just selling medicine. It’s just like sales person. 
So it’s a lot of wasted thing. [C2] 
I think they [pharmacists] also like doctor, they 
should go for courses, upgrading themselves because I 
think in medication or in any medicine, you still have 
to keep up, keeping yourself up [...] Why not? Medicine  
you should. [C3]
When given examples on potential extended pharmacist 
roles established overseas such as vaccine administration 
and medicine dosage adjustment, the participants gave split 
opinions on pharmacists performing such roles. Participants 
who supported these extended roles were confident with the 
clinical ability of Malaysian pharmacists to carry out such 
roles. However, other participants remained doubtful of 
Malaysian pharmacists and if they were capable of carrying 
out such activities effectively. 
I think we should go ahead with it. Because you all are 
qualified pharmacist, you have gone through course, I think 
you all have, should have the right to help […] to alter or 
to increase or to reduce because you all know better. [C3]
The quality of our pharmacist to some extent it’s 
questionable here in Malaysia due to various factors and 
I would not be very comfortable if the doctor we has not 
been consulted if you are  changing my dosage. So, yea 
I would split my view into two. [C6]
Confidence	and	trust	in	pharmacists
Almost all participants were not confident to have a non-
pharmacist (often they are non-trained health professionals) 
dispensing medications currently at the private GP clinics.
They normally only employ people who are out from form 
5 [referring to high school leavers] to be a so called clinical 
nurse, how much knowledge they have. I don’t think they 
have that much knowledge. [C3]
I don’t know whether there is ethic issue or not to put 
the unqualified nurse in those health care [GP] clinics. I’m 
quite worry about that especially if you bring your kids 
right to those clinics. [C24]
Two participants mentioned that public health clinics 
and public hospitals have pharmacists to dispense medicines 
unlike non-pharmacists in private GP clinics.
In the public health clinic they have actually the pharmacist 
sitting there, is not a nurse right. [C24]
In hospitals the pharmacist explain. But in [GP] clinics 
normally they [non-pharmacist] don’t explain. They just 
give you the medication and you take according to what 
they have told you. [C4]
Participants felt dispensing medications in private GP 
clinics should be best carried out by a pharmacist to allow 
counter-checking of prescribed medicines and to provide 
advice on the side effects of medicines. Some participants 
also hoped pharmacists can check for appropriateness and 
necessity of the medications supplied. In doing so, all par-
ticipants felt that pharmacists should have access to their 
medical records.
I don’t think they [non-pharmacist in GP clinics] have that 
much knowledge. So I feel for dispensing the drugs it’s 
better to have a pharmacist, a qualified pharmacist. [C3]
So it is actually good to have two different people doing 
it. Because there will be actually like a check and balance 
that sort of thing instead of one person diagnosing and 
prescribing. [C11]
If the person dispensing the medicine to us can enlighten 
us and further on the side effects of the medicine and 
whether there are any other alternatives compared to what 
they have dispense and make us more knowledgeable then 
we can make a better choice. [C12]
And then you know you go to the GP they will prescribe 
all sort of unnecessary, sometimes you don’t need it also they 
will prescribe for you, through my experience [...] So I feel 
you know it should be in a proper I mean as a clinic, private 
clinic especially, qualified pharmacist there. [C3]
I’m ok with that [accessing medical records]. Because 
they can keep track of our condition each time right. So I 
think this is their responsibility also. [C1]
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Most participants agreed that pharmacists integrated into 
private GP clinics will spend more time discussing medicine-
related issues with the consumers because GPs are more often 
too busy to do so. 
The pharmacist will spend more time with the patient to 
explain things. So if you [pharmacist] are able to explain to 
them [consumers] and tell them you know, the importance 
of taking the medication on a timely basis, why they must 
stick [to it], that will be better. [C12]
Sometimes doctors are too busy. They cannot like go 
through every detail with you. Will they spend half an hour 
with you? No way! Pharmacist can help out in that way you 
know. [C3]
Some participants revealed that they have trust issues 
with pharmacists adopting additional clinical roles without 
consulting GPs first. Participants were unsure of the phar-
macists’ qualification and level of knowledge.
The quality of our pharmacist to some extent it’s question-
able here in Malaysia. I would not be very comfortable if 
the doctor we has not been consulted if you are changing 
my dosage. [C6]
All participants revealed that Malaysian consumers 
are generally very doctor-centered in seeking medical 
treatment and health advice. Participants strongly felt that 
public education and awareness on the roles of pharmacists 
is important.
Because the mentality is already there that means if you 
are sick you need to go to doctor. Doctor is the one giving 
you medicine. It’s all been 50, 60, 100 years. [C22]
I think for a start is the role, the role of the pharmacist. 
How the pharmacist can actually help us? Yea, to create an 
awareness because these days is that if we are actually sick 
we just go to GP. That’s it you know. [C11]
Overall, participants viewed potential benefits in phar-
macist integration into private GP clinics and were generally 
comfortable with the concept. 
Pharmacist really know a lot of medications, what we should 
be given, not to be given, age limits for toddlers. Over the 
counter they can see the patient, at least they can interact. 
So when the pharmacist inside this private health care clinic, 
it will be safer to consumers. [C22]
I would say that it’s the role of the pharmacist, if it’s 
well regulated and to be actually assured of the quality of the 
services, yes then go ahead and have them integrated. [C11]
Participants felt that a higher salary, additional work 
benefits, and an improved public awareness toward the roles 
of pharmacists in Malaysia can facilitate pharmacist integra-
tion into private GP clinics.
I think it’s the salary. Must be higher. It depends on the 
benefit. [C1]
So for a start, perhaps you should consider creating the 
awareness. What is the, how pharmacist can actually help, 
perhaps even better. What is the role of the pharmacist as 
compared to the physician? How best that you can do to 
help, to have a, to be healthy. [C11]
consumers’ willingness to pay for 
pharmacy services
Participants were concerned that the total cost of the treat-
ment may increase and be passed on to consumers. Majority 
did not want to bear an extra cost of treatment. 
Right now we don’t pay any services for the pharmacy. 
If I think they want to charge for fees, I will not pay for 
that because we pay the doctors, now we have to pay the 
pharmacists. [C2]
Some participants indicated that they are willing to pay for 
the service, ranging from RM 10–50 depending on the type 
of services offered by the pharmacist. Only a few participants 
were very willing to pay extra for pharmacy services. 
I mean of course you must first show that you are capable 
of giving these kind of service to people, like we said, build 
up the confidence. People also will  pay willingly and then 
pharmacist also get their pay. [C15]
Participants felt that the government should provide 
some form of support or subsidy to pharmacists to work in 
the GP clinic. 
The government should actually fund them [pharmacists]. The 
government should play a role in, because this is health care. 
They are collecting taxes so they should have a portion of it 
for pharmacist and that portion should be given as a grant or as 
a yearly basis for the pharmacist to run their pharmacy. [C4]
concerns about gPs’ resistance 
to pharmacist integration 
All participants were concerned that a pharmacist in private 
GP clinics would encroach into the roles of GPs and impinge 
into GPs’ income. They agreed this would result in GPs’ 
resistance to pharmacist integration. 
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Right now the GP are dispensing the medicine, so if you 
put somebody there, so I think they  will not like it. [C2]
And to actually taking over a small portion of GPs’ 
rice bowl. So that is also a hurdle you know. So how are 
you going to convince and persuade. Aside from the profit 
you are actually removing some functions away from them. 
How are you going to do that? [C11]
Participants also felt that integrating a pharmacist into 
private GP clinics would incur more cost to the GPs. They 
felt that GPs in the rural areas may face difficulty to operate 
under such set-up. 
Wait, I’m sure the doctors won’t like it cause they will 
cough out more money to pay [the] pharmacist? [C14]
You may also face problem in rural areas. I would 
think places like east coast, east Malaysia [to face the same 
problem]. [C8]
I do not see how a private clinic is going to employ a 
pharmacist. Because I think it is expensive. They not only 
just to, you know, to provide a service but the same time 
they also earning income  you see. So if they employ a 
pharmacist it will be kind of financially burdened to them 
in that sense. [C12]
Putting cost issues aside, all participants strongly felt 
that GPs and pharmacists should work together toward bet-
ter patient care. Participants understood that GPs and phar-
macists have separate roles which would complement one 
another and contribute toward providing a comprehensive 
patient care, ie, GPs responsible for diagnosis and treatment 
and pharmacists as medicine experts. 
I think it’s a duty of care, a split of duty of care between 
these two very important roles. [C6]
It will be good to us if we too have that kind of integra-
tion. That mean we leave to the expert for doctor the expert 
is to know the disease, then for pharmacist the expert is 
to give the correct medicine according to the symptom 
 [C10]
Discussion
Our results indicate that participants were generally support-
ive of integrating a pharmacist into a GP clinic. Participants 
strongly agreed that dispensing medications in private GP 
clinics should be carried out by registered pharmacists. In 
doing so, pharmacists are able to screen for medication errors, 
drug–drug interactions, and engaging with consumers for 
further medication-related enquiries. This corresponds to 
previous studies on medication-related needs of consumers 
who expressed their main concerns in medication adverse 
effects.34,35 Therefore, a pharmacist integrated into a GP 
clinic can help to alleviate the medication-related concerns 
of health care consumers.
Although participants acknowledged pharmacists as 
medication experts, they indicated greater support for non-
medication-related roles such as “healthy living” advice. This 
is also described in a pilot study on the proposed new roles 
of community pharmacists in the UK.36
When given examples of other potential roles of phar-
macists beyond dispensing in the GP clinics such as medi-
cation dosage adjustment and vaccination, participants had 
difficulty envisioning the expanded activities pharmacists 
are capable of undertaking. These reservations may stem 
from the limited interactions many participants have with 
pharmacists in community pharmacies. Similarly in a study 
by Freeman et al when participants were asked to discuss 
what roles they would perceive a pharmacist undertaking 
within a general practice setting, their responses resembled 
services already offered by pharmacists externally.31 A pilot 
study in the UK by Iversen et al also showed that consumers 
of pharmacy services may not be entirely supportive of the 
expanding role of the pharmacist, probably due to the lack 
of understanding of pharmacists’ expertise.36 The results of 
this study also suggested that engagement of pharmacists in 
health improvement activities tend to be passive and product-
orientated. Literature also indicates that pharmacists tend 
to take a reactive rather than proactive approach to health 
promotion activity.37 
There were issues surrounding the degree of involvement 
a pharmacist should have with consumers. Participants’ 
response to the role of pharmacists appeared at times to 
be contradictory. When asked in a theoretical way about 
whether they perceive the pharmacist as medication expert 
able to adopt more clinical roles, participants’ response 
tends to be cautious, suggesting that consumers generally 
have low expectations toward the role of pharmacists. Some 
participants are undoubtedly willing to take up the advice and 
services offered by a pharmacist, and it appears that they are 
regular clients who obtain their medicines from pharmacists. 
Similarly in a study by Gidman et al38 consumers were often 
reluctant to trust pharmacists to deliver unfamiliar services, 
particularly consumers with long-standing health conditions 
were perceived to be at “high risk” and preferred a GP-led 
service at all times. 
It was apparent that participants were concerned with 
GPs’ perceptions in the introduction of a new member into 
the private general practice. Some participants felt GPs 
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may feel threatened by this new role, an opinion shared by 
GPs in international studies.39,40 On the contrary, previous 
studies conducted have found that prescribers welcomed 
new extended roles of practicing pharmacists as counselors 
and drug information providers, especially in developed 
nations.31,41,42 Due to differing health care systems and fund-
ing models, input from other key stakeholders especially GPs 
and pharmacists is critical. Nevertheless, consumers felt that 
multidisciplinary collaboration between GPs and pharmacists 
is vital for the betterment of patient care. Some participants 
suggested the need for multidisciplinary education and devel-
opment of collaborative working relationships.
This study found no commonly agreed reimbursement 
structure. Most participants responded that the fee-for-service 
model would further increase health care cost to consumers. 
Unlike the GPs’ consultation fee which is governed by the 
Schedule of Fees in Malaysia, the participants were not able 
to quantify an amount to pay for pharmacist services because 
they cannot visualize the services to be provided and the out-
come of the service provision. In many instances, pharmacists 
are not compensated for health promotion or disease preven-
tion and management activities.43 The majority of participants 
considered pharmacists to be both business people and health 
care professionals and these views are supported by a study 
carried out by Hargie et al in the UK.44 The participants urged 
Malaysian pharmacists and the Malaysian Pharmaceutical 
Society to undertake ethical responsibilities toward their 
consumers and adopt a more patient-oriented approach. 
Overall findings showed that the participants’ felt barri-
ers to pharmacist integration into private GP clinics include 
GPs’ resistance and potential increase in health care cost to 
consumers. To overcome these barriers, some participants felt 
that pharmacists need to portray credibility and competence. 
Government support to fund pharmacists in private GP clinics 
was seen as the major facilitator, with practices that embrace 
a multidisciplinary approach perceived as being more accom-
modating of pharmacist integration into private GP clinics. 
The findings from this study will be useful to health 
care policy makers and could influence changes in the way 
pharmacists practice. The interpretation of the results may be 
limited by the confined area the participants were recruited 
from. The convenience nature of the sample has the potential 
to positively bias the results. However, as a general rule pri-
mary health care policy and practice is uniform nationwide. 
To reduce interviewer bias, seeding questions common to 
all the focus groups and semi-structured interviews were 
used to facilitate discussion. Being a qualitative study, the 
findings of this study cannot be generalized to all consumers 
in Malaysia. This study however helps to guide and develop 
future studies within the area. 
Conclusion 
Consumers generally supported pharmacist integration into 
private GP clinics. However, for pharmacists to expand 
their capacity in providing integrated and collaborative 
primary care services to consumers, barriers to pharmacist 
integration need to be addressed. Future research should 
further explore the methods of collaboration and trial their 
implementation. 
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